Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI)
€ 88.2 0.4 (0.46%) Market Cap: 4.51 Bil Enterprise Value: 4.55 Bil PE Ratio: 33.53 PB Ratio: 8.48 GF Score: 88/100

Half Year 2021 Laboratorios Farmaceuticos ROVI SA Earnings Presentation Transcript

Jul 28, 2021 / 01:00PM GMT
Release Date Price: €63 (+4.48%)
Javier Lopez;Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO

Presentation
Jul 28, 2021 / 01:00PM GMT

=====================
Corporate Participants
=====================
* Javier Lopez-Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO
* Juan Lopez-Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - CEO & Director
* Marta Campos Martínez

=====================
- -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot